Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 266

1.

[Non-small cell lung cancer].

Yoshimura A, Niitani H.

Ryoikibetsu Shokogun Shirizu. 1994;(4):100-3. Review. Japanese. No abstract available.

PMID:
8007089
2.

Non-small cell lung cancer: issues in diagnosis, staging and treatment.

Harwood KV.

Semin Oncol Nurs. 1987 Aug;3(3):183-93. No abstract available.

PMID:
3039637
3.

Evolution and future perspectives in the treatment of locally advanced non-small cell lung cancer.

Toschi L, Cappuzzo F, Jänne PA.

Ann Oncol. 2007 Jul;18 Suppl 9:ix150-5. Review. No abstract available.

4.

Non-small cell lung cancer.

Ettinger DS, Akerley W, Bepler G, Blum MG, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW Jr, Jahan T, Jahanzeb M, Johnson DH, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Le QT, Lennes IT, Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Rohren E, Simon GR, Swanson SJ, Wood DE, Yang SC; NCCN Non-Small Cell Lung Cancer Panel Members.

J Natl Compr Canc Netw. 2010 Jul;8(7):740-801. Review. No abstract available.

PMID:
20679538
5.

Locally advanced non-small cell lung cancer: different strategies for different diseases.

Antonelli G, Priolo D, Vitale F, Ferraù F.

Ann Oncol. 2006 Mar;17 Suppl 2:ii24-27. Review. No abstract available.

6.

Practice guidelines for non-small cell lung cancer.

Cameron R, Fringer J, Taylor C, Gilden CR, Figlin RA.

Cancer J Sci Am. 1996 May-Jun;2(3A Suppl):S61-8. No abstract available.

PMID:
9166525
7.

Recent advances in diagnosis and treatment of small cell and non-small cell lung cancer.

Sørensen JB, Hansen HH.

Curr Opin Oncol. 1994 Mar;6(2):162-70. Review.

PMID:
8011693
8.

Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement.

Lynch TJ, Bogart JA, Curran WJ Jr, DeCamp MM, Gandara DR, Goss G, Henschke CI, Jett JR, Johnson BE, Kelly KL, Le Chevalier T, Mulshine JL, Scagliotti GV, Schiller JH, Shaw A, Thatcher N, Vokes EE, Wood DE, Hart C.

Clin Cancer Res. 2005 Jul 1;11(13 Pt 2):4981s-4983s. No abstract available.

9.

Stage IIIA N2 non-small-cell lung cancer: current controversies in combined-modality therapy.

Thomas PA.

Eur J Cardiothorac Surg. 2009 Sep;36(3):431-2. doi: 10.1016/j.ejcts.2009.04.024. Epub 2009 Jun 12. No abstract available.

PMID:
19524447
10.

Non-small cell lung cancer.

Ettinger DS, Akerley W, Bepler G, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Feigenberg SJ, Figlin RA, Govindan R, Grannis FW Jr, Jahan T, Jahanzeb M, Kessinger A, Komaki R, Kris MG, Langer CJ, Le QT, Martins R, Otterson GA, Patel JD, Robert F, Sugarbaker DJ, Wood DE.

J Natl Compr Canc Netw. 2008 Mar;6(3):228-69. No abstract available.

PMID:
18377844
11.

[Non-small-cell bronchial cancer: update in 1998].

Mornex F.

Cancer Radiother. 1998 Sep-Oct;2(5):566-7. French. No abstract available.

PMID:
9868401
12.

Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

D'Addario G, Felip E; ESMO Guidelines Working Group.

Ann Oncol. 2008 May;19 Suppl 2:ii39-40. doi: 10.1093/annonc/mdn081. No abstract available.

13.

[Treatment of non-small cell lung cancer].

Solignac M.

Presse Med. 2000 Jul 1;29(23):1328-31. French. No abstract available.

PMID:
10923144
14.

Adjuvant and neoadjuvant therapy for stages I through III non-small cell lung cancer.

Rusch VW.

Ann Thorac Surg. 1994 Sep;58(3):899-900. No abstract available.

PMID:
7944732
15.

Pattern of lymphatic spread and prognosis in pN1 non-small cell lung cancer: what does it stand for?

Margaritora S, Cesario A, Granone P.

J Thorac Cardiovasc Surg. 2003 Nov;126(5):1664-5; author reply 1665-6. No abstract available.

PMID:
14666060
16.

Non-small cell lung cancer: early stages.

Bria E, Ceribelli A, Trovò MG, Gelibter A, Gigante M, Calabrò E, Cuppone F, Cognetti F, Terzoli E, Pastorino U.

Ann Oncol. 2006 Mar;17 Suppl 2:ii17-21. Review. No abstract available.

17.

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC).

Felip E, Stahel RA, Pavlidis N; ESMO Guidelines Task Force.

Ann Oncol. 2005;16 Suppl 1:i28-9. No abstract available.

18.

Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer.

D'Angelillo RM, Trodella L, Ramella S.

J Thorac Cardiovasc Surg. 2004 Sep;128(3):489-90. No abstract available.

19.

[Locally advanced and metastatic non-small-cell lung cancer: towards a new optimal therapeutic strategy].

Fournel P.

Rev Pneumol Clin. 2004 Jun;60 Spec no 2:2S8-15. Review. French. No abstract available.

PMID:
15211226
20.

Stage IIIB non-small-cell lung cancer.

Rendina EA, Venuta F, De Giacomo T, Furio Coloni G.

Chest Surg Clin N Am. 2001 Feb;11(1):101-19, viii. Review.

PMID:
11253593
Items per page

Supplemental Content

Write to the Help Desk